Under 40s News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Out to under 40s and probably declare my interest in this matter, as i do. on the wider vaccine roll—out, members across the house would've been frustrated and concerned with reports this weekend that too many hospital beds and resources are having to be diverted to those who have chosen not to receive the vaccine. with the pressures on the nhs this winter expected to reach unprecedented levels, even before the emergence of omicron, what is the secretary of state plan for the one in five people who are eligible, but not yet fully vaccinated to get the jab. the arguments in favour of receivin...

Posed by the new variant, the gap between the second dose and the booster would be reduced from six months to three and it would be available to under—40s and people have been turning up at walk—in vaccination centres hoping that it will happen straightaway and it hasn�*t and some have been asked to go away and just come back when they are invited. there are some key messages. don�*t come in for your booster unless you are invited. but secondly, the mechanics on the national booking website are not there yet. and the vaccinators and the people running the vaccine centres have not got t...

But it is something that is just not quite as available here on our shores, so this is going to allocate a lot more money so that people can get tests and take those test at home so if they are symptomatic, they are not spreading those germs further. the plans announced today also make emergency response teams available to all us states and are going to accelerate the delivery of vaccines to other countries. scientists believe they have found what causes extremely rare blood clots in a small number of people who have had the astrazeneca covid vaccine. the team, based in cardiff and the us, has...

Will disappear in a few days. adam fleming. the uk drug regulator has approved a new antibody treatment for covid—19. the treatment, formulated by glaxo smith kline and vir biotechnology, is called xevudy and is for people with mild—to—moderate covid who are at high risk of developing severe disease. gsk says early analysis also shows it works against the omicron variant. scientists believe they have found what causes extremely rare blood clots in a small number of people who have had the astrazeneca covid vaccine. the team — based in cardiff and the us — has discovered that a protei...

You. adam- _ as you've been hearing, the current booster shot campaign is being significantly ramped up — with a plan to offer it to all eligible adults in england by the end of january. let's find out how the rollout is going. dr emily ball is a gp in liverpool. welcome and thank you very much for joining us. it is nearly a week since borisjohnson said it would be rolled out to under 40s. where are things now? it seems like it's not been completelyjoined up with gps. i think it is the usual story, isn't it? the average gp found out that we would be doing this on the news that the same time ...